Skip to main content

Breast Cancer Treatment | A. Prof. Pieter Eichhorn

PODCAST

From chemotherapy to immunotherapy and targeted drug delivery, what’s next for breast cancer treatment? 

In this episode, Jessica is joined by cancer research expert Associate Professor Pieter Eichhorn, who is co-leading an Australian Government subsidised drug delivery project that aims to change the behaviours of proteins found in breast cancer. 

Together, they discuss what conventional treatments exist and where they’re going, Associate Professor Eichhorn’s exciting new drug treatment, and what he believes needs to change to drastically reduce the rates of breast cancer going into the future.

Associate Professor Eichhorn’s research project is supported by the Curtin Health Innovation Research Institute and the National Drug Discovery Centre at the Walter and Eliza Hall Institute.

How breast cancer develops [01:15]

Predicting future rates of breast cancer [04:26]

Progress in conventional treatments [07:56]

What’s unique about the drug delivery project? [13:27]

Associate Professor Eichhorn’s research journey [17:34]

Reducing rates of cancer through tumour sequencing [19:45] 

Content note: This episode predominantly covers the experiences of women who are cisgender. Cisgender women are those women whose sense of their gender matches the sex they were assigned at birth and who are the population group at greatest risk of contracting breast cancer.

Learn more

WEHI: National Drug Discovery Centre announces new projects

National Breast Cancer Foundation website

Breast Cancer Now website

Connect with our guest

Pieter Eichhorn is the Dean of Research Infrastructure at Curtin University, and an Associate Professor at the world-renowned Curtin Health Innovation Research Institute.

He has devoted his career to developing targeted treatments for breast cancer and melanoma patients. Prior to Curtin, he has worked at a variety of prestigious institutes including Harvard Medical School, Massachusetts General Hospital, the Cancer Science Institute of Singapore and the Netherlands Cancer Institute. 

Associate Professor Eichhorn’s staff profile

Associate Professor Eichhorn’s LinkedIn profile

Curtin Health Innovation Research Institute website

Join Curtin University

This podcast is brought to you by Curtin University. Curtin is a global university known for its commitment to making positive change happen through high-impact research, strong industry partnerships and practical teaching.

Partner with Curtin

Study a research degree

Start postgraduate education

Got any questions, or suggestions for future topics?

Email thefutureof@curtin.edu.au

Socials

https://twitter.com/curtinuni

https://www.facebook.com/curtinuniversity

https://www.instagram.com/curtinuniversity/

https://www.youtube.com/user/CurtinUniversity

https://www.linkedin.com/school/curtinuniversity/

 

Transcript

https://thefutureof.simplecast.com/episodes/breast-cancer-treatment/transcript


Behind the scenes team

Jessica Morrison, Host

Anita Shore, Executive Producer

Annabelle Fouchard, Producer

Daniel Jauk, Episode Researcher, Recordist and Editor

Alexandra Eftos, Assistant Producer

Amy Hosking, Social Media.

 

Curtin University supports academic freedom of speech. The views expressed in The Future Of podcast may not reflect those of Curtin University.

 

First Nations Acknowledgement

Curtin University acknowledges the traditional owners of the land on which Curtin Perth is located, the Whadjuk people of the Nyungar Nation, and on Curtin Kalgoorlie, the Wongutha people of the North-Eastern Goldfields; and the First Nations peoples on all Curtin locations.

 

Music

OKAY by 13ounce Creative Commons — Attribution-ShareAlike 3.0 Unported — CC BY-SA 3.0 Music promoted by Audio Library.